Covering U.S. Technology and Life Sciences IPOs, de-SPAC Mergers and Direct Listings
Technology and life sciences companies went public at an extraordinary rate in the first half of 2021 and they continued to do so via different paths: initial public offerings, de-SPAC mergers and direct listings.
Our report focuses on U.S. and foreign technology and life sciences companies that went public in the U.S. in the first half of 2021.
Key highlights include:
- IPOs outpaced the second half of 2020, which was previously the most active six months for the space since we began tracking in 2012.
- The de-SPAC (special purpose acquisition company) merger surge also continued: the number of tech and life sciences companies to go public via SPAC merger in the first half of 2021 increased 71 percent from the second half of 2020.
- The four direct listings in H1 2021 were double the number in the previous half year and included Fenwick client Coinbase Global's blockbuster Nasdaq direct listing.
Downloading the full report will provide you
access to a number of tables and charts that offer a graphical view
of key parameters as well as a sense of recent trends.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.